BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28441873)

  • 1. Identification and Characterization of a Secondary Sodium-Binding Site and the Main Selectivity Determinants in the Human Concentrative Nucleoside Transporter 3.
    Arimany-Nardi C; Claudio-Montero A; Viel-Oliva A; Schmidtke P; Estarellas C; Barril X; Bidon-Chanal A; Pastor-Anglada M
    Mol Pharm; 2017 Jun; 14(6):1980-1987. PubMed ID: 28441873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cation coupling properties of human concentrative nucleoside transporters hCNT1, hCNT2 and hCNT3.
    Smith KM; Slugoski MD; Cass CE; Baldwin SA; Karpinski E; Young JD
    Mol Membr Biol; 2007; 24(1):53-64. PubMed ID: 17453413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The broadly selective human Na+/nucleoside cotransporter (hCNT3) exhibits novel cation-coupled nucleoside transport characteristics.
    Smith KM; Slugoski MD; Loewen SK; Ng AM; Yao SY; Chen XZ; Karpinski E; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 2005 Jul; 280(27):25436-49. PubMed ID: 15870078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of a nucleoside-derived drug transporter variant (hCNT3C602R) showing altered sodium-binding capacity.
    Errasti-Murugarren E; Cano-Soldado P; Pastor-Anglada M; Casado FJ
    Mol Pharmacol; 2008 Feb; 73(2):379-86. PubMed ID: 17993510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted cysteine accessibility method (SCAM) analysis of the transport domain of human concentrative nucleoside transporter 3 (hCNT3) and other family members reveals features of structural and functional importance.
    Mulinta R; Yao SYM; Ng AML; Cass CE; Young JD
    J Biol Chem; 2017 Jun; 292(23):9505-9522. PubMed ID: 28385889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inward- and outward-facing homology modeling of human concentrative nucleoside transporter 3 (hCNT3) predicts an elevator-type transport mechanism.
    Yao SYM; Young JD
    Channels (Austin); 2018; 12(1):291-298. PubMed ID: 30096006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conformationally mobile cysteine residue (Cys-561) modulates Na+ and H+ activation of human CNT3.
    Slugoski MD; Smith KM; Mulinta R; Ng AM; Yao SY; Morrison EL; Lee QO; Zhang J; Karpinski E; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 2008 Sep; 283(36):24922-34. PubMed ID: 18621735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosetta Broker for membrane protein structure prediction: concentrative nucleoside transporter 3 and corticotropin-releasing factor receptor 1 test cases.
    Latek D
    BMC Struct Biol; 2017 Aug; 17(1):8. PubMed ID: 28774292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proton-mediated conformational shift identifies a mobile pore-lining cysteine residue (Cys-561) in human concentrative nucleoside transporter 3.
    Slugoski MD; Ng AM; Yao SY; Smith KM; Lin CC; Zhang J; Karpinski E; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 2008 Mar; 283(13):8496-507. PubMed ID: 18199742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib).
    Ritzel MW; Ng AM; Yao SY; Graham K; Loewen SK; Smith KM; Hyde RJ; Karpinski E; Cass CE; Baldwin SA; Young JD
    Mol Membr Biol; 2001; 18(1):65-72. PubMed ID: 11396613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human concentrative nucleoside transporter-3 C602R variant shows impaired sorting to lipid rafts and altered specificity for nucleoside-derived drugs.
    Errasti-Murugarren E; Molina-Arcas M; Casado FJ; Pastor-Anglada M
    Mol Pharmacol; 2010 Aug; 78(2):157-65. PubMed ID: 20421346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homology Modeling of Human Concentrative Nucleoside Transporters (hCNTs) and Validation by Virtual Screening and Experimental Testing to Identify Novel hCNT1 Inhibitors.
    Kumar Deokar H; Barch HP; Buolamwini JK
    Drug Des; 2017 Mar; 6(1):. PubMed ID: 29167753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conserved glutamate residues Glu-343 and Glu-519 provide mechanistic insights into cation/nucleoside cotransport by human concentrative nucleoside transporter hCNT3.
    Slugoski MD; Smith KM; Ng AML; Yao SYM; Karpinski E; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 2009 Jun; 284(25):17266-17280. PubMed ID: 19380587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of benzopyranone derivatives and related compounds with human concentrative nucleoside transporters 1, 2 and 3 heterologously expressed in porcine PK15 nucleoside transporter deficient cells. Structure-activity relationships and determinants of transporter affinity and selectivity.
    Wang C; Pimple S; Buolamwini JK
    Biochem Pharmacol; 2010 Feb; 79(3):307-20. PubMed ID: 19735647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of the human concentrative nucleoside transporter-1 variant hCNT1S546P provides insight into the sodium-binding pocket.
    Cano-Soldado P; Gorraitz E; Errasti-Murugarren E; Casado FJ; Lostao MP; Pastor-Anglada M
    Am J Physiol Cell Physiol; 2012 Jan; 302(1):C257-66. PubMed ID: 21998139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of amino acid residues responsible for the pyrimidine and purine nucleoside specificities of human concentrative Na(+) nucleoside cotransporters hCNT1 and hCNT2.
    Loewen SK; Ng AM; Yao SY; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 1999 Aug; 274(35):24475-84. PubMed ID: 10455109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1.
    Damaraju VL; Smith KM; Mowles D; Nowak I; Karpinski E; Young JD; Robins MJ; Cass CE
    Biochem Pharmacol; 2011 Jan; 81(1):82-90. PubMed ID: 20854794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substituted cysteine accessibility method analysis of human concentrative nucleoside transporter hCNT3 reveals a novel discontinuous region of functional importance within the CNT family motif (G/A)XKX3NEFVA(Y/M/F).
    Slugoski MD; Ng AML; Yao SYM; Lin CC; Mulinta R; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 2009 Jun; 284(25):17281-17292. PubMed ID: 19380585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uridine binding motifs of human concentrative nucleoside transporters 1 and 3 produced in Saccharomyces cerevisiae.
    Zhang J; Visser F; Vickers MF; Lang T; Robins MJ; Nielsen LP; Nowak I; Baldwin SA; Young JD; Cass CE
    Mol Pharmacol; 2003 Dec; 64(6):1512-20. PubMed ID: 14645682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uridine binding and transportability determinants of human concentrative nucleoside transporters.
    Zhang J; Smith KM; Tackaberry T; Visser F; Robins MJ; Nielsen LP; Nowak I; Karpinski E; Baldwin SA; Young JD; Cass CE
    Mol Pharmacol; 2005 Sep; 68(3):830-9. PubMed ID: 15955867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.